NIH #R01CA284604
Optimizing TCR-CD3 signaling for immunotherapy of cancer
Active
- Amount
- $600K–$700K
- Period
- 2024-04-10 → 2029-03-31
- PIs
- 2
Awarded at NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Hu Chen
Full Professor(heuristic)
Genetics, Bioinformatics, and Biomedical Research · Molecular Biology
Compare more Molecular Biology professors.
h-index34
i10-index68
Publications198
Citations5,000
Grants
5 total · 5 active
NIH #U01CA280984
Dysregulated mechanoimmunology of epigenetics-driven lymphomas
Active
- Amount
- $500K–$600K
- Period
- 2023-05-09 → 2028-04-30
- PIs
- 2
Awarded at GEORGIA INSTITUTE OF TECHNOLOGY
NIH #R01AG081362
Silencing of astrocytic MAGL as a therapy for Alzheimer’s disease
Active
- Amount
- $700K–$800K
- Period
- 2023-04-15 → 2028-03-31
- PIs
- 1
Awarded at UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →
Recent Public Signals
- New paper: Single-nucleus profiling reveals a core disease signature and cell type–specific vulnerabilities in early Rett syndrome (Science Advances)2026-06-10
- New NIH award: Mechanosensing through the B cell antigen receptor2026-02-19
- New preprint: Reinforcement learning enables single-cell foundation models to learn cellular differentiation2025-12-12
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data Freshness
- Publications as of 2026-07-09
- Grants as of 2026-09-03
Data may not be current
Find elsewhere
ORCID: 0000-0001-5472-7158